{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T08:44:05Z","timestamp":1769071445767,"version":"3.49.0"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.cca.2020.08.013","type":"journal-article","created":{"date-parts":[[2020,8,11]],"date-time":"2020-08-11T21:18:07Z","timestamp":1597180687000},"page":"488-497","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["Potential diagnostics and therapeutic approaches in COVID-19"],"prefix":"10.1016","volume":"510","author":[{"given":"Pratibha","family":"Kumari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Archana","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moses Rinchui","family":"Ngasainao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0919-5556","authenticated-orcid":false,"given":"Ilma","family":"Shakeel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjay","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seema","family":"Lal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anchal","family":"Singhal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SS","family":"Sohal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Indrakant Kumar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MI","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2020.08.013_b0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.chaos.2020.109794","article-title":"Modeling and forecasting of epidemic spreading: the case of covid-19 and beyond","volume":"135","author":"Boccaletti","year":"2020","journal-title":"Chaos, Solitons Fractals"},{"key":"10.1016\/j.cca.2020.08.013_b0010","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.jinf.2020.02.020","article-title":"Novel coronavirus disease (Covid-19): the first two patients in the UK with person to person transmission","volume":"80","author":"Lillie","year":"2020","journal-title":"J. Infect."},{"key":"10.1016\/j.cca.2020.08.013_b0015","doi-asserted-by":"crossref","first-page":"9490","DOI":"10.1073\/pnas.2004168117","article-title":"Effectiveness of convalescent plasma therapy in severe COVID-19 patients","volume":"117","author":"Duan","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.cca.2020.08.013_b0020","doi-asserted-by":"crossref","DOI":"10.1093\/molbev\/msaa094","article-title":"Extreme Genomic CpG Deficiency in SARS-CoV-2 and Evasion of Host Antiviral Defense","author":"Xia","year":"2020","journal-title":"Mol. Biol. Evol."},{"key":"10.1016\/j.cca.2020.08.013_b0025","first-page":"1837","article-title":"Turbulent gas clouds and respiratory pathogen emissions: potential implications for reducing transmission of COVID-19","volume":"323","author":"Bourouiba","year":"2020","journal-title":"JAMA"},{"issue":"15","key":"10.1016\/j.cca.2020.08.013_b0030","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1093\/cid\/ciaa149","article-title":"Consistent Detection of 2019 Novel Coronavirus in Saliva","volume":"71","author":"To","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.cca.2020.08.013_b0035","unstructured":"Organization WH. Modes of transmission of virus causing COVID-19: implications for IPC precaution recommendations. https:\/\/www.who.int\/news-room\/commentaries\/detail\/modes-of-transmission-of-virus-causing-covid-19-implications-for-ipc-precaution-recommendations (29 March 2020)."},{"key":"10.1016\/j.cca.2020.08.013_b0040","doi-asserted-by":"crossref","unstructured":"Hoffmann M, Kleine-Weber H, Schroeder S et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor, Cell 2020, Shang J, Wan Y, Luo C et al. Cell entry mechanisms of SARS-CoV-2, Proceedings of the National Academy of Sciences 2020;117:11727-11734.","DOI":"10.1073\/pnas.2003138117"},{"key":"10.1016\/j.cca.2020.08.013_b0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev-virology-012420-022445","article-title":"Seasonality of Respiratory Viral Infections","volume":"7","author":"Moriyama","year":"2020","journal-title":"Annu. Rev. Virol."},{"key":"10.1016\/j.cca.2020.08.013_b0050","doi-asserted-by":"crossref","unstructured":"Shereen MA, Khan S, Kazmi A et al. COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses, Journal of Advanced Research 2020, He F, Deng Y, Li W. Coronavirus disease 2019: What we know?, Journal of medical virology 2020;92:719-725.","DOI":"10.1002\/jmv.25766"},{"key":"10.1016\/j.cca.2020.08.013_b0055","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","article-title":"Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein","volume":"181","author":"Walls","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.cca.2020.08.013_b0060","doi-asserted-by":"crossref","unstructured":"Naqvi AAT, Fatima K, Mohammad T et al. Insights into SARS-CoV-2 genome, structure, evolution, pathogenesis and therapies: Structural genomics approach, Biochim Biophys Acta Mol Basis Dis 2020:165878.","DOI":"10.1016\/j.bbadis.2020.165878"},{"key":"10.1016\/j.cca.2020.08.013_b0065","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20201256","article-title":"Glecaprevir and Maraviroc are high-affinity inhibitors of SARS-CoV-2 main protease: possible implication in COVID-19 therapy","volume":"40","author":"Shamsi","year":"2020","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.cca.2020.08.013_b0070","doi-asserted-by":"crossref","first-page":"e174","DOI":"10.3346\/jkms.2020.35.e174","article-title":"Prevalence and duration of acute loss of smell or taste in COVID-19 patients","volume":"35","author":"Lee","year":"2020","journal-title":"J. Korean Med. Sci."},{"key":"10.1016\/j.cca.2020.08.013_b0075","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan","volume":"395","author":"Huang","year":"2020","journal-title":"China, The Lancet"},{"key":"10.1016\/j.cca.2020.08.013_b0080","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus\u2013infected pneumonia in Wuhan China","volume":"323","author":"Wang","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.cca.2020.08.013_b0085","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","article-title":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","volume":"395","author":"Chen","year":"2020","journal-title":"The Lancet"},{"key":"10.1016\/j.cca.2020.08.013_b0090","first-page":"1843","article-title":"Detection of SARS-CoV-2 in different types of clinical specimens","volume":"323","author":"Wang","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.cca.2020.08.013_b0095","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41586-020-2196-x","article-title":"Virological assessment of hospitalized patients with COVID-2019","volume":"581","author":"W\u00f6lfel","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.cca.2020.08.013_b0100","doi-asserted-by":"crossref","first-page":"2000045","DOI":"10.2807\/1560-7917.ES.2020.25.3.2000045","article-title":"Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR","volume":"25","author":"Corman","year":"2020","journal-title":"Eurosurveillance"},{"key":"10.1016\/j.cca.2020.08.013_b0105","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.cmi.2020.04.001","article-title":"Rapid and visual detection of 2019 novel coronavirus (SARS-CoV-2) by a reverse transcription loop-mediated isothermal amplification assay","volume":"26","author":"Yan","year":"2020","journal-title":"Clin. Microbiol. Infect."},{"issue":"7","key":"10.1016\/j.cca.2020.08.013_b0110","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1261\/rna.076232.120","article-title":"Overcoming the bottleneck to widespread testing: a rapid review of nucleic acid testing approaches for COVID-19 detection","volume":"26","author":"Esbin","year":"2020","journal-title":"RNA"},{"key":"10.1016\/j.cca.2020.08.013_b0115","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciaa344","article-title":"Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019","author":"Zhao","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.cca.2020.08.013_b0120","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3201\/eid1002.030731","article-title":"Serologic and molecular biologic methods for SARS-associated coronavirus infection Taiwan","volume":"10","author":"Wu","year":"2004","journal-title":"Emerging Infectious Diseases"},{"key":"10.1016\/j.cca.2020.08.013_b0125","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jproteome.0c00412","article-title":"Mass Spectrometric detection of SARS-CoV-2 virus in scrapings of the epithelium of the nasopharynx of infected patients via Nucleocapsid N protein","author":"Nikolaev","year":"2020","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.cca.2020.08.013_b0130","unstructured":"World Health Organization. \u201cWHO Director-General's opening remarks at the media briefing on COVID-19 \u2013 11 March 2020\u201d. https:\/\/www.who.int\/dg\/speeches\/detail\/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020 (11 March 2020."},{"key":"10.1016\/j.cca.2020.08.013_b0135","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.2214\/AJR.20.22954","article-title":"Coronavirus disease 2019 (COVID-19): role of chest CT in diagnosis and management","volume":"214","author":"Li","year":"2020","journal-title":"Am. J. Roentgenol."},{"issue":"6","key":"10.1016\/j.cca.2020.08.013_b0140","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.2214\/AJR.20.22954","article-title":"Coronavirus Disease 2019 (COVID-19): Role of Chest CT in Diagnosis and Management","volume":"14","author":"Li","year":"2020","journal-title":"AJR Am. J. Roentgenol"},{"key":"10.1016\/j.cca.2020.08.013_b0145","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1007\/s00330-020-06731-x","article-title":"Initial CT findings and temporal changes in patients with the novel coronavirus pneumonia (2019-nCoV): a study of 63 patients in Wuhan","volume":"30","author":"Pan","year":"2020","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.cca.2020.08.013_b0150","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jinf.2020.03.033","article-title":"Clinical and CT imaging features of 2019 novel coronavirus disease (COVID-19)","volume":"81","author":"Zhu","year":"2020","journal-title":"The Journal of infection"},{"key":"10.1016\/j.cca.2020.08.013_b0155","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3348\/kjr.2020.0096","article-title":"Pneumonia associated with 2019 novel coronavirus: can computed tomographic findings help predict the prognosis of the disease?","volume":"21","author":"Lee","year":"2020","journal-title":"Korean J. Radiol."},{"key":"10.1016\/j.cca.2020.08.013_b0160","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S1473-3099(20)30086-4","article-title":"Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study","volume":"20","author":"Shi","year":"2020","journal-title":"Lancet. Infect. Dis"},{"key":"10.1016\/j.cca.2020.08.013_b0165","doi-asserted-by":"crossref","first-page":"3989","DOI":"10.1039\/C5AN00407A","article-title":"Colorimetric detection of influenza A virus using antibody-functionalized gold nanoparticles","volume":"140","author":"Liu","year":"2015","journal-title":"Analyst"},{"key":"10.1016\/j.cca.2020.08.013_b0170","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1021\/ac203102u","article-title":"Robust and Highly Sensitive Fluorescence Approach for Point-of-Care Virus Detection Based on Immunomagnetic Separation","volume":"84","author":"Zhao","year":"2012","journal-title":"Anal. Chem."},{"key":"10.1016\/j.cca.2020.08.013_b0175","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ijbiomac.2017.01.093","article-title":"Impedimetric genosensor for detection of hepatitis C virus (HCV1) DNA using viral probe on methylene blue doped silica nanoparticles","volume":"98","author":"Singhal","year":"2017","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.cca.2020.08.013_b0180","doi-asserted-by":"crossref","first-page":"3892","DOI":"10.1039\/C6SC00412A","article-title":"Rapid electrochemical detection of single influenza viruses tagged with silver nanoparticles","volume":"7","author":"Sepunaru","year":"2016","journal-title":"Chem. Sci."},{"key":"10.1016\/j.cca.2020.08.013_b0185","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.bios.2013.03.021","article-title":"Electrochemical immunosensor with graphene quantum dots and apoferritin-encapsulated Cu nanoparticles double-assisted signal amplification for detection of avian leukosis virus subgroup J","volume":"47","author":"Wang","year":"2013","journal-title":"Biosens. Bioelectron."},{"key":"10.1016\/j.cca.2020.08.013_b0190","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.bios.2016.05.050","article-title":"Enhanced catalytic activity of gold nanoparticle-carbon nanotube hybrids for influenza virus detection","volume":"85","author":"Ahmed","year":"2016","journal-title":"Biosens. Bioelectron."},{"key":"10.1016\/j.cca.2020.08.013_b0195","doi-asserted-by":"crossref","first-page":"5135","DOI":"10.1021\/acsnano.0c02823","article-title":"Rapid Detection of COVID-19 Causative Virus (SARS-CoV-2) in Human Nasopharyngeal Swab Specimens Using Field-Effect Transistor-Based Biosensor","volume":"14","author":"Seo","year":"2020","journal-title":"ACS. Nano."},{"key":"10.1016\/j.cca.2020.08.013_b0200","doi-asserted-by":"crossref","first-page":"10970","DOI":"10.1073\/pnas.2005615117","article-title":"Effective treatment of severe COVID-19 patients with tocilizumab","volume":"117","author":"Xu","year":"2020","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"10.1016\/j.cca.2020.08.013_b0205","doi-asserted-by":"crossref","first-page":"58","DOI":"10.5582\/ddt.2020.01012","article-title":"Discovering drugs to treat coronavirus disease 2019 (COVID-19)","volume":"14","author":"Dong","year":"2020","journal-title":"Drug Discoveries & Therapeutics"},{"key":"10.1016\/j.cca.2020.08.013_b0210","doi-asserted-by":"crossref","first-page":"198102","DOI":"10.1016\/j.virusres.2020.198102","article-title":"Identification of high-affinity inhibitors of SARS-CoV-2 main protease: towards the development of effective COVID-19 therapy","author":"Mohammad","year":"2020","journal-title":"Virus Res."},{"key":"10.1016\/j.cca.2020.08.013_b0215","doi-asserted-by":"crossref","unstructured":"Cao Y-c, Deng Q-x, Dai S-x. Remdesivir for severe acute respiratory syndrome coronavirus 2 causing COVID-19: An evaluation of the evidence, Travel medicine and infectious disease 2020:101647, Agostini ML, Andres EL, Sims AC et al. Coronavirus susceptibility to the antiviral remdesivir (GS-5734) is mediated by the viral polymerase and the proofreading exoribonuclease, MBio 2018;9:e00221-00218.","DOI":"10.1016\/j.tmaid.2020.101647"},{"key":"10.1016\/j.cca.2020.08.013_b0225","doi-asserted-by":"crossref","unstructured":"Amirian ES, Levy JK. Current knowledge about the antivirals remdesivir (GS-5734) and GS-441524 as therapeutic options for coronaviruses, One Health 2020:100128.","DOI":"10.1016\/j.onehlt.2020.100128"},{"issue":"6498","key":"10.1016\/j.cca.2020.08.013_b0230","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1126\/science.abc1560","article-title":"Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir","volume":"368","author":"Yin","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.cca.2020.08.013_b0235","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0140-6736(20)31022-9","article-title":"Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial","volume":"395","author":"Wang","year":"2020","journal-title":"The Lancet"},{"key":"10.1016\/j.cca.2020.08.013_b0240","doi-asserted-by":"crossref","first-page":"100710","DOI":"10.1016\/j.nmni.2020.100710","article-title":"Influence of conflicts of interest on public positions in the COVID-19 era, the case of Gilead Sciences","author":"Roussel","year":"2020","journal-title":"New Microbes and New Infections"},{"issue":"7","key":"10.1016\/j.cca.2020.08.013_b0245","doi-asserted-by":"crossref","first-page":"e039730","DOI":"10.1136\/bmjopen-2020-039730","article-title":"Favipiravir for treating patients with novel coronavirus (COVID-19): protocol for a systematic review and meta-analysis of randomised clinical trials","volume":"10","author":"Arab-Zozani","year":"2020","journal-title":"BMJ open"},{"key":"10.1016\/j.cca.2020.08.013_b0250","unstructured":"ClinicalTrials.gov. Treatments for COVID-19: Canadian Arm of the SOLIDARITY Trial (CATCO). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04330690 (5 May 2020)."},{"key":"10.1016\/j.cca.2020.08.013_b0255","unstructured":"ClinicalTrials.gov. COVID MED Trial - Comparison Of Therapeutics for Hospitalized Patients Infected With SARS-CoV-2 (COVIDMED). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04328012 (8 April 2020)."},{"key":"10.1016\/j.cca.2020.08.013_b0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijid.2020.07.053","article-title":"SARS-CoV-2 Clearance in COVID-19 Patients with Novaferon Treatment: A Randomized, Open-label, Parallel Group Trial","author":"Zheng","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.cca.2020.08.013_b0265","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1473-3099(06)70361-9","article-title":"New insights into the antiviral effects of chloroquine","volume":"6","author":"Savarino","year":"2006","journal-title":"Lancet. Infect. Dis"},{"key":"10.1016\/j.cca.2020.08.013_b0270","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","article-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.cca.2020.08.013_b0275","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1056\/NEJMoa2012410","article-title":"Observational study of hydroxychloroquine in hospitalized patients with covid-19","volume":"382","author":"Geleris","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cca.2020.08.013_b0280","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jcrc.2020.03.005","article-title":"A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19","volume":"57","author":"Cortegiani","year":"2020","journal-title":"J. Crit. Care"},{"key":"10.1016\/j.cca.2020.08.013_b0285","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2019014","article-title":"Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19","author":"Cavalcanti","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cca.2020.08.013_b0290","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s40264-018-0689-4","article-title":"Cardiac complications attributed to chloroquine and hydroxychloroquine: a systematic review of the literature","volume":"41","author":"Chatre","year":"2018","journal-title":"Drug safety"},{"key":"10.1016\/j.cca.2020.08.013_b0295","unstructured":"Drug Bank. Auranofin. https:\/\/www.drugbank.ca\/drugs\/DB00995."},{"key":"10.1016\/j.cca.2020.08.013_b0300","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.virol.2020.05.002","article-title":"The FDA-approved gold drug auranofin inhibits novel coronavirus (SARS-COV-2) replication and attenuates inflammation in human cells","volume":"547","author":"Rothan","year":"2020","journal-title":"Virology"},{"key":"10.1016\/j.cca.2020.08.013_b0305","doi-asserted-by":"crossref","DOI":"10.1126\/science.abc4739","article-title":"New York clinical trial quietly tests heartburn remedy against coronavirus","author":"Borrell","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.cca.2020.08.013_b0310","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.26633\/RPSP.2020.40","article-title":"Clinical trials on drug repositioning for COVID-19 treatment","volume":"44","author":"Rosa","year":"2020","journal-title":"Revista Panamericana de Salud P\u00fablica"},{"key":"10.1016\/j.cca.2020.08.013_b0315","first-page":"1","article-title":"The Janus kinase 1\/2 inhibitor ruxolitinib in COVID-19 with severe systemic hyperinflammation","author":"La Ros\u00e9e","year":"2020","journal-title":"Leukemia"},{"key":"10.1016\/j.cca.2020.08.013_b0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinf.2020.04.017","article-title":"Baricitinib therapy in COVID-19: A pilot study on safety and clinical impact","author":"Cantini","year":"2020","journal-title":"The Journal of Infection"},{"issue":"7","key":"10.1016\/j.cca.2020.08.013_b0325","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1002\/jmv.25798","article-title":"Novel coronavirus treatment with ribavirin: Groundwork for an evaluation concerning COVID-19","volume":"92","author":"Khalili","year":"2020","journal-title":"J Med Virol"},{"key":"10.1016\/j.cca.2020.08.013_b0330","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1136\/thorax.2003.012658","article-title":"Role of lopinavir\/ritonavir in the treatment of SARS: initial virological and clinical findings","volume":"59","author":"Chu","year":"2004","journal-title":"Thorax"},{"key":"10.1016\/j.cca.2020.08.013_b0335","doi-asserted-by":"crossref","first-page":"104787","DOI":"10.1016\/j.antiviral.2020.104787","article-title":"The FDA-approved Drug Ivermectin inhibits the replication of SARS-CoV-2 in vitro","volume":"178","author":"Caly","year":"2020","journal-title":"Antiviral Res."},{"key":"10.1016\/j.cca.2020.08.013_b0340","unstructured":"FDA. FDA Letter to Stakeholders: Do Not Use Ivermectin Intended for Animals as Treatment for COVID-19 in Humans. https:\/\/www.fda.gov\/animal-veterinary\/product-safety-information\/fda-letter-stakeholders-do-not-use-ivermectin-intended-animals-treatment-covid-19-humans (10 April 2020)."},{"key":"10.1016\/j.cca.2020.08.013_b0345","article-title":"Management of corona virus disease-19 (COVID-19): the Zhejiang experience","volume":"49","author":"Xu","year":"2020","journal-title":"J. Zhejiang Univ. (Med. Sci.)"},{"key":"10.1016\/j.cca.2020.08.013_b0350","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/j.jinf.2020.03.060","article-title":"Arbidol monotherapy is superior to lopinavir\/ritonavir in treating COVID-19","volume":"81","author":"Zhu","year":"2020","journal-title":"J. Infect."},{"issue":"7","key":"10.1016\/j.cca.2020.08.013_b0355","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1093\/ofid\/ofaa241","article-title":"Antiviral Activity and Safety of Darunavir\/Cobicistat for the Treatment of COVID-19","volume":"7","author":"Chen","year":"2020","journal-title":"Open Forum Infect. Dis."},{"key":"10.1016\/j.cca.2020.08.013_b0360","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/s41594-020-0440-6","article-title":"Structural basis for the inhibition of SARS-CoV-2 main protease by antineoplastic drug carmofur","volume":"27","author":"Jin","year":"2020","journal-title":"Nat. Struct. Mol. Biol."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898120303958?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898120303958?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:00:19Z","timestamp":1757862019000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898120303958"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":71,"alternative-id":["S0009898120303958"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2020.08.013","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potential diagnostics and therapeutic approaches in COVID-19","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2020.08.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}